Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network · 2025-05 · 23 (5) · 169-191
DOI: 10.6004/jnccn.2025.0022 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025-05. Verfasst von Jaffer A Ajani und 41 weiteren Autor:innen. Beteiligte Einrichtung: The University of Texas MD Anderson Cancer Center. Hauptthemen laut MEDLINE: Stomach Neoplasms, Medical Oncology. Die Arbeit wurde bisher 251-mal zitiert (Crossref) und nennt 199 Literaturangaben.
Abstract (Originalsprache)
Gastric cancer is the fifth leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type. Gastric cancer generally carries a poor prognosis because it is often diagnosed at an advanced stage. Systemic therapy can provide palliation, improve survival, and enhance the quality of life in patients with locally advanced or metastatic disease. The implementation of biomarker testing has had a significant impact on clinical practice and patient care. Targeted therapies have demonstrated encouraging results in clinical trials for the treatment of patients with locally advanced or metastatic disease. This selection from the NCCN Clinical Practice Guidelines in Oncology for Gastric Cancer highlights recommendations for biomarker testing and discusses updates for the treatment of advanced disease, including peritoneal carcinoma as only disease and unresectable locally advanced, recurrent, or metastatic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The University of Texas MD Anderson Cancer Center.
- Duke Cancer Institute.
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
- UCSF Helen Diller Family Comprehensive Cancer Center.
- Dana-Farber/Brigham and Women's Cancer Center.
- University of Michigan Rogel Cancer Center.
Zitieren
APA
Ajani, J. A., D'Amico, T. A., Bentrem, D. J., Corvera, C. U., Das, P., Enzinger, P. C., Enzler, T., Gerdes, H., Gibson, M. K., Grierson, P., Gupta, G., Hofstetter, W. L., Ilson, D. H., Jalal, S., Kim, S., Kleinberg, L. R., Klempner, S., Lacy, J., Lee, B., …, & Stein, M. (2025). Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network, 23(5), 169-191. https://doi.org/10.6004/jnccn.2025.0022
Vancouver
Ajani JA, D'Amico TA, Bentrem DJ, Corvera CU, Das P, Enzinger PC, et al. Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network. 2025;23(5):169-191. doi:10.6004/jnccn.2025.0022
BibTeX
@article{Ajani2025,
author = {Ajani, Jaffer A and D'Amico, Thomas A and Bentrem, David J and Corvera, Carlos U and Das, Prajnan and Enzinger, Peter C and Enzler, Thomas and Gerdes, Hans and Gibson, Michael K and Grierson, Patrick and Gupta, Garima and Hofstetter, Wayne L and Ilson, David H and Jalal, Shadia and Kim, Sunnie and Kleinberg, Lawrence R and Klempner, Samuel and Lacy, Jill and Lee, Byrne and Licciardi, Frank and Lloyd, Shane and Ly, Quan P and Matsukuma, Karen and McNamara, Michael and Merkow, Ryan P and Miller, Aaron M and Mukherjee, Sarbajit and Mulcahy, Mary F and Perry, Kyle A and Pimiento, Jose M and Reddi, Deepti M and Reznik, Scott and Roses, Robert E and Strong, Vivian E and Su, Stacey and Uboha, Nataliya and Wainberg, Zev A and Willett, Christopher G and Woo, Yanghee and Yoon, Harry H and McMillian, Nicole R and Stein, MaryElizabeth},
title = {Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2025},
volume = {23},
number = {5},
pages = {169--191},
doi = {10.6004/jnccn.2025.0022}
}
EUVIMED